Morbidity and Mortality of Orthostatic Hypotension: Implications for Management of Cardiovascular Disease

被引:99
作者
Benvenuto, Luke J. [1 ]
Krakoff, Lawrence R. [1 ]
机构
[1] Mt Sinai Hosp, Div Cardiol, Mt Sinai Sch Med, Dept Internal Med, New York, NY 10029 USA
关键词
asymptomatic orthostatic hypotension; blood pressure; cardiovascular risk; hypertension; orthostatic hypotension; postural hypotension; BLOOD-PRESSURE CHANGES; HIGH VASCULAR RISK; BAROREFLEX SENSITIVITY; ATHEROSCLEROSIS RISK; OLDER-PEOPLE; MULTIFACTORIAL INTERVENTION; PREDICTS MORTALITY; COGNITIVE DECLINE; CORONARY-DISEASE; ELDERLY-PEOPLE;
D O I
10.1038/ajh.2010.146
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Orthostatic hypotension (OH) is the failure of cardiovascular reflexes to maintain blood pressure on standing from a supine or sitting position. Although OH may cause symptoms of dizziness or syncope, asymptomatic OH (AOH) is far more common and is an independent risk factor for mortality and cardiovascular disease (CVD). The prevalence of AOH increases with age, the presence of hypertension or diabetes and the use of antihypertensive or other medications. The implications of AOH for the treatment of CVD and hypertension are not well defined. This review provides an overview of the current information on this topic and recommends the more frequent assessment of OH in clinical practice and in future clinical trials.
引用
收藏
页码:135 / 144
页数:10
相关论文
共 85 条
[1]   Frequency of orthostatic hypotension in a community based cohort of patients with Parkinson's disease [J].
Allcock, LM ;
Ullyart, K ;
Kenny, RA ;
Burn, DJ .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2004, 75 (10) :1470-1471
[2]  
Amery A, 1991, Aging (Milano), V3, P287
[3]  
[Anonymous], 1997, Clin Exp Pharmacol Physiol, V24, P188
[4]  
Antihypertensive T., 2002, JAMA-J AM MED ASSOC, V288, P2981, DOI [10.1001/jama.288.23.2981, DOI 10.1001/JAMA.288.23.2981]
[5]   Treatment of hypertension in patients 80 years of age or older [J].
Beckett, Nigel S. ;
Peters, Ruth ;
Fletcher, Astrid E. ;
Staessen, Jan A. ;
Liu, Lisheng ;
Dumitrascu, Dan ;
Stoyanovsky, Vassil ;
Antikainen, Riitta L. ;
Nikitin, Yuri ;
Anderson, Craig ;
Belhani, Alli ;
Forette, Francoise ;
Rajkumar, Chakravarthi ;
Thijs, Lutgarde ;
Banya, Winston ;
Bulpitt, Christopher J. .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (18) :1887-1898
[6]   Orthostatic fall in blood pressure in the very elderly hypertensive: results from the Hypertension in the Very Elderly Trial (HYVET) - pilot [J].
Beckett, NS ;
Connor, M ;
Sadler, JD ;
Fletcher, AE ;
Bulpitt, CJ .
JOURNAL OF HUMAN HYPERTENSION, 1999, 13 (12) :839-840
[7]   Rationale and design for the controlled onset verapamil investigation of cardiovascular endpoints (CONVINCE) trial [J].
Black, HR ;
Elliott, WJ ;
Neaton, JD ;
Grandits, G ;
Grambsch, P ;
Grimm, RH ;
Hansson, L ;
Lacoucière, Y ;
Muller, J ;
Sleight, P ;
Weber, MA ;
White, WB ;
Williams, G ;
Wittes, J ;
Zanchetti, A ;
Fakouhi, TD .
CONTROLLED CLINICAL TRIALS, 1998, 19 (04) :370-390
[8]   Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) Trial [J].
Black, HR ;
Elliott, WJ ;
Grandits, G ;
Grambsch, P ;
Lucente, T ;
White, WB ;
Neaton, JD ;
Grimm, RH ;
Hansson, L ;
Lacourcière, Y ;
Muller, J ;
Sleight, P ;
Weber, MA ;
Williams, G ;
Wittes, J ;
Zanchetti, A ;
Anders, RJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (16) :2073-2082
[9]   Hypertension in the Very Elderly Trial (HYVET) - Protocol for the Main Trial [J].
Bulpitt, C ;
Fletcher, A ;
Beckett, N ;
Coope, J ;
Gil-Extremera, B ;
Forette, F ;
Nachev, C ;
Potter, J ;
Sever, P ;
Staessen, J ;
Swift, C ;
Tuomilehto, J .
DRUGS & AGING, 2001, 18 (03) :151-164
[10]   STRUCTURAL VERSUS FUNCTIONAL MODULATION OF THE ARTERIAL BAROREFLEX [J].
CHAPLEAU, MW ;
CUNNINGHAM, JT ;
SULLIVAN, MJ ;
WACHTEL, RE ;
ABBOUD, FM .
HYPERTENSION, 1995, 26 (02) :341-347